Abstract
Most recipients of simultaneous pancreas-kidney transplants experience acute rejection in the early postoperative course. We report our experience with four recipients of simultaneous pancreas-kidney transplants with acute rejection who were effectively treated with the combination of intravenous and oral FK506 therapy. This spared these patients an extra course of monoclonal or polyclonal antibody.
| Original language | English |
|---|---|
| Pages (from-to) | 785-788 |
| Number of pages | 4 |
| Journal | Transplantation |
| Volume | 63 |
| Issue number | 5 |
| DOIs | |
| State | Published - Mar 15 1997 |
Fingerprint
ASJC Scopus subject areas
- Transplantation
- Immunology
Cite this
Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. / Ciancio, Gaetano; Burke, George W; Roth, David; Miller, Joshua.
In: Transplantation, Vol. 63, No. 5, 15.03.1997, p. 785-788.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506
AU - Ciancio, Gaetano
AU - Burke, George W
AU - Roth, David
AU - Miller, Joshua
PY - 1997/3/15
Y1 - 1997/3/15
N2 - Most recipients of simultaneous pancreas-kidney transplants experience acute rejection in the early postoperative course. We report our experience with four recipients of simultaneous pancreas-kidney transplants with acute rejection who were effectively treated with the combination of intravenous and oral FK506 therapy. This spared these patients an extra course of monoclonal or polyclonal antibody.
AB - Most recipients of simultaneous pancreas-kidney transplants experience acute rejection in the early postoperative course. We report our experience with four recipients of simultaneous pancreas-kidney transplants with acute rejection who were effectively treated with the combination of intravenous and oral FK506 therapy. This spared these patients an extra course of monoclonal or polyclonal antibody.
UR - http://www.scopus.com/inward/record.url?scp=0030969992&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030969992&partnerID=8YFLogxK
U2 - 10.1097/00007890-199703150-00030
DO - 10.1097/00007890-199703150-00030
M3 - Article
VL - 63
SP - 785
EP - 788
JO - Transplantation
JF - Transplantation
SN - 0041-1337
IS - 5
ER -